Science of AMD Newsfeed
- Novartis Provides Update on Use and Safety of Beovu in Patients With Wet AMD
- Beovu Approved for Wet AMD in European Union
- AMD Incidence to Rise by 75% and Affect 77 million Europeans by 2050
- Opthea OPT-302 Combo Outshines Lucentis Alone
- Positive phase 2 trial results of anti-VEGF abicipar pegol for treating wet AMD
- Vitreous separation in wet AMD patients linked to fewer anti-VEGF injections
- As-needed anti-VEGF regimen shown to be effective for the treatment of wet AMD
- Greatest vision gains occur during early stages of anti-VEGF treatment for wet AMD
- Potential Topical Treatment in the Future for Macular Degeneration
- MicroRNAs Block Abnormal Blood Vessel Growth While Still Maintaining the Health of Normal Vessels
- New Treatment Approach in Mice Regresses Abnormal Vessels in Wet Macular Degeneration
- Discussions on the Retina and AMD from the American Academy of Opthalmology 2013: Hear from the Experts
- New Initiative by the American Academy of Ophthalmology Harnesses Technology to Improve Patient Outcomes